News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Frank Kelly, Jr. Appointed to InVasc Therapeutics Board of Directors


9/20/2010 9:44:54 AM

ATLANTA--(BUSINESS WIRE)--InVasc Therapeutics, Inc., a biopharmaceutical company focused on chronic kidney and cardiometabolic diseases, announced today the appointment of Frank Kelly, Jr. to its Board of Directors. Mr. Kelly brings forty years of experience in finance, marketing and operations to InVasc.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES